Sapient Capital’s HCA Healthcare HCA Stock Holding History

Sapient Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-844	Closed	-$399K	–	439
2026 Q1	$399K	Buy	+844	New	+$425K	0.01%	307

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sapient Capital's HCA Position: Q2 2026 in Review

Sapient Capital sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 844 shares — an estimated $399K sold.

Sapient Capital first reported a position in HCA in Q1 2026 and held it in 1 quarter. The position peaked at $399K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Sapient Capital reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
Sapient Capital sold 844 HCA Healthcare shares in Q2 2026, an estimated $399K.
Sapient Capital first reported a position in HCA Healthcare in Q1 2026 and held it in 1 quarter.
Sapient Capital's HCA Healthcare position peaked at $399K in Q1 2026.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.